What is NovoNutrients?
Based in Sunnyvale, California, NovoNutrients operates at the intersection of biotechnology and industrial sustainability. The company utilizes a sophisticated process involving industrial carbon dioxide emissions, hydrogen, and naturally occurring microbes to synthesize high-quality proteins. By repurposing waste streams into essential nutrients, NovoNutrients addresses critical challenges in food security and environmental impact. This circular economy approach positions the firm as a key player in the green technology sector, offering a scalable solution for industries seeking to reduce their carbon footprint while simultaneously producing sustainable feed ingredients for the aquaculture market.
How much funding has NovoNutrients raised?
NovoNutrients has raised a total of $22.7M across 2 funding rounds:
Unspecified
$4.7M
Series A
$18M
Unspecified (2021): $4.7M with participation from Happiness Capital
Series A (2024): $18M led by Woodside Energy and CM Venture Capital
Key Investors in NovoNutrients
Woodside Energy
Woodside Energy is a prominent player in the global Oil and Energy sector, focusing on large-scale energy production and strategic investments in sustainable industrial technologies.
CM Venture Capital
CM Venture Capital is a specialized investment firm that targets hard tech and science-backed innovations, with a particular focus on energy systems and sustainable industrial transformation.
Happiness Capital
Happiness Capital is an investment entity that supports early-stage ventures, contributing to the growth trajectory of companies focused on impactful and sustainable technological solutions.
What's next for NovoNutrients?
Following this major enterprise-level funding, NovoNutrients is well-positioned to accelerate its commercialization efforts and scale its production infrastructure. The strategic backing from energy-focused entities suggests a clear trajectory toward integrating gas-fermentation facilities with industrial emission sources. As the company moves beyond the development phase, the focus will likely shift toward optimizing operational efficiency and expanding its market reach within the global protein supply chain. Investors are closely monitoring the firm's ability to translate its scientific breakthroughs into consistent, large-scale industrial output, which remains the primary catalyst for long-term value creation in the sustainable biotechnology space.
See full NovoNutrients company page
